Literature DB >> 11316519

Natural and synthetic inhibitors of UDP-glucuronosyltransferase.

K Grancharov1, Z Naydenova, S Lozeva, E Golovinsky.   

Abstract

Glucuronidation is a major detoxification pathway in vertebrates. The reaction is catalyzed by a family of UDP-glucuronosyltransferases (UGTs) and involves conjugation of many endobiotic and xenobiotic substances with glucuronic acid, forming inactive water-soluble glucuronides. UGT prevents the accumulation of potentially toxic compounds and/or their subsequent bioactivation to more toxic intermediates, although biologically active glucuronides are also known. Impairment of UGTs may have important toxicological consequences. Substances found to inhibit or down-regulate UGT activity include endogenous compounds, a wide range of clinically used drugs, environmental contaminants, and natural toxic substances present in the diet. The development of selective, active-site-directed UGT inhibitors greatly enables the study of various UGT isoenzymes. A promising approach offers the design of transition-state analogs of the glucuronidation reaction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316519     DOI: 10.1016/s0163-7258(00)00109-1

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  8 in total

1.  Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes.

Authors:  Michael J Osborne; Luciana Coutinho de Oliveira; Laurent Volpon; Hiba Ahmad Zahreddine; Katherine L B Borden
Journal:  J Mol Biol       Date:  2018-11-11       Impact factor: 5.469

2.  Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin.

Authors:  Alex E Grill; Brenda Koniar; Jayanth Panyam
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

3.  KNIME workflow for retrieving causal drug and protein interactions, building networks, and performing topological enrichment analysis demonstrated by a DILI case study.

Authors:  Barbara Füzi; Rahuman S Malik-Sheriff; Emma J Manners; Henning Hermjakob; Gerhard F Ecker
Journal:  J Cheminform       Date:  2022-06-13       Impact factor: 8.489

4.  Human xylosyltransferase I: functional and biochemical characterization of cysteine residues required for enzymic activity.

Authors:  Sandra Müller; Manuela Schöttler; Sylvia Schön; Christian Prante; Thomas Brinkmann; Joachim Kuhn; Christian Götting; Knut Kleesiek
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

5.  Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.

Authors:  Michael J Miley; Agnieszka K Zielinska; Jeffrey E Keenan; Stacie M Bratton; Anna Radominska-Pandya; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2007-03-30       Impact factor: 5.469

6.  The Reproductive Toxicity Associated with Dodonaea viscosa, a Folk Medicinal Plant in Saudi Arabia.

Authors:  Muhammad Farooq Khan; Ali S Alqahtani; Omer M Almarfadi; Riaz Ullah; Fahd A Nasr; Omar M Noman; Nasir A Siddiqui; Abdelaaty A Shahat; Syed Rizwan Ahamad
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-15       Impact factor: 2.629

7.  Inhibitory effects of UDP-glucuronosyltransferase (UGT) typical ligands against E. coli beta-glucuronidase (GUS).

Authors:  Ling Xiao; Dehui Chi; Guiju Sheng; Wenjuan Li; Penghui Lin; Sicheng Liang; Liangliang Zhu; Peipei Dong
Journal:  RSC Adv       Date:  2020-06-16       Impact factor: 3.361

8.  Antigenotoxic Effects and Possible Mechanism of Red Yeast (Sporidiobolus pararoseus) on Aflatoxin B1-Induced Mutagenesis.

Authors:  Romteera Kittichaiworakul; Sirinya Taya; Arpamas Chariyakornkul; Thanongsak Chaiyaso; Rawiwan Wongpoomchai
Journal:  Biomolecules       Date:  2021-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.